Penumbra, Inc. (PEN)
320.99
+0.22
(+0.07%)
USD |
NYSE |
Nov 13, 16:00
320.99
0.00 (0.00%)
After-Hours: 19:59
Penumbra Enterprise Value : 12.18B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 12.18B |
| November 11, 2026 | 12.22B |
| November 10, 2026 | 12.21B |
| November 09, 2026 | 12.22B |
| November 06, 2026 | 12.12B |
| November 05, 2026 | 12.19B |
| November 04, 2026 | 12.24B |
| November 03, 2026 | 12.15B |
| November 02, 2026 | 12.20B |
| October 30, 2026 | 12.11B |
| October 29, 2026 | 12.23B |
| October 28, 2026 | 12.08B |
| October 27, 2026 | 12.31B |
| October 26, 2026 | 12.35B |
| October 23, 2026 | 12.32B |
| October 22, 2026 | 12.34B |
| October 21, 2026 | 12.29B |
| October 20, 2026 | 12.32B |
| October 19, 2026 | 12.24B |
| October 16, 2026 | 12.18B |
| October 15, 2026 | 12.20B |
| October 14, 2026 | 12.15B |
| October 13, 2026 | 12.15B |
| October 12, 2026 | 12.19B |
| October 09, 2026 | 12.12B |
| Date | Value |
|---|---|
| October 08, 2026 | 12.05B |
| October 07, 2026 | 12.00B |
| October 06, 2026 | 12.03B |
| October 05, 2026 | 12.03B |
| October 02, 2026 | 12.05B |
| October 01, 2026 | 12.07B |
| September 30, 2026 | 12.08B |
| September 29, 2026 | 12.11B |
| September 28, 2026 | 12.13B |
| September 25, 2026 | 12.11B |
| September 24, 2026 | 12.15B |
| September 23, 2026 | 12.14B |
| September 22, 2026 | 12.13B |
| September 21, 2026 | 12.11B |
| September 18, 2026 | 12.06B |
| September 17, 2026 | 12.11B |
| September 16, 2026 | 12.10B |
| September 15, 2026 | 12.10B |
| September 14, 2026 | 12.15B |
| September 11, 2026 | 12.07B |
| September 10, 2026 | 12.07B |
| September 09, 2026 | 12.14B |
| September 08, 2026 | 12.13B |
| September 04, 2026 | 12.24B |
| September 03, 2026 | 12.20B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp. | 75.60B |
| Teleflex, Inc. | 7.440B |
| Integra LifeSciences Holdings Corp. | 2.807B |
| Globus Medical, Inc. | 9.182B |
| Abbott Laboratories | 213.21B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 42.28M |
| Revenue (Quarterly) | 410.14M |
| Total Expenses (Quarterly) | 367.87M |
| EPS Diluted (Quarterly) | 1.067 |
| Gross Profit Margin (Quarterly) | 67.03% |
| Profit Margin (Quarterly) | 10.31% |
| Earnings Yield | 1.24% |
| Operating Earnings Yield | 1.49% |
| Normalized Earnings Yield | 1.238 |